Sign In
Buy GTLL
$0.0001
+0 (+0%)
At Close: Aug 05, 2026
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
08:05am, Thursday, 28'th May 2026
WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of
Varex to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management
Monster Beverage Announces Participation in dbAccess Global Consumer Conference 2026
08:00am, Thursday, 28'th May 2026
CORONA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) announced today that members of its senior management team will participate in a fireside chat at the dbAcc
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging it
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
EMERYVILLE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new stan
Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference
08:00am, Thursday, 28'th May 2026
NEW YORK--(BUSINESS WIRE)--Warby Parker Inc. (NYSE: WRBY) (the “Company”), a lifestyle brand focused on vision for all, today announced that the Company will be presenting at the 2026 Baird Global
Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
CARLSBAD, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, tod
Prime Medicine to Present at Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapie
Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapie
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, to
CoinShares CEO Jean-Marie Mognetti to Participate in the Piper Sandler Global Exchange & Fintech Conference in New York
08:00am, Thursday, 28'th May 2026
JERSEY, Channel Islands — May 28, 2026 — CoinShares PLC (Nasdaq: CSHR) ("CoinShares" or the "Company"), a leading global asset manager specializing in digital assets, today announced that Presiden
Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference
07:30am, Thursday, 28'th May 2026
NEWTON, Mass., May 28, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
07:30am, Thursday, 28'th May 2026
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the Jeffe
CI Global Asset Management Announces Special Reinvested Distribution for CI ICBCUBS S&P China 500 Index ETF (CHNA.B)
07:00am, Thursday, 28'th May 2026
TORONTO--(BUSINESS WIRE)---- $CHNA.B #CIFinancial--CI Global Asset Management announces a special reinvested distribution for CI ICBCUBS S&P China 500 Index ETF (TSX: CHNA.B).
